Henry Schein Q1 revenue down 3.8% to $3.1B; non-GAAP EPS $1.21 vs $1.44; lowers 2023 guidance to $5.18-$5.35

HENRY SCHEIN INC

2023-Q1 EPS reported $0.91 revenue$3,060,000,000

GAAP diluted EPS $0.91 vs $1.30; non-GAAP diluted EPS $1.21 vs $1.44.
Net sales $3.1B, down 3.8% YoY; internal sales grew 6.3% ex-PPE and COVID test kits.
Global Medical sales $1.0B down 17.2% (up 4.2% ex-PPE/COVID test kits); Dental $1.9B up 3.8%.
2023 non-GAAP EPS guidance cut to $5.18-$5.35 from prior $5.38; includes $0.05-$0.10 Biotech Dental dilution.
Repurchased 1.2M shares for $100M in Q1; $415M remains authorized for buybacks.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HENRY SCHEIN INC reported the first quarter ended April 1, 2023 results: revenue $3.1 billion, net income $121 million, EPS $0.91.

Period: the first quarter ended April 1, 2023
Revenue: $3.1 billion
Net income: $121 million
EPS: $0.91
Result: reported results

Exact text from the filing

2 exhibit991.htm PRESS RELEASE MAY 9, 2023 exhibit991 -1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS ● First-quarter 2023 net sales of $3.1 billion decreased 3.8% compared with first-quarter 2022; internal sales increased 6.3% in local currencies excluding sales of personal protective equipment (PPE) products and COVID-19

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HENRY SCHEIN INC reported full-year 2023 results: EPS $5.18 to $5.35. Guidance lowered.

Period: full-year 2023
EPS: $5.18 to $5.35
Guidance: lowered
Result: guidance update

Exact text from the filing

Updating full-year 2023 non-GAAP diluted EPS guidance to $5.18 to $5.35, reflecting an estimated $0.05 to $0.10 first year dilution from the Biotech Dental acquisition

View on SEC.gov

Browse all earnings releases →

HENRY SCHEIN INC filing history →

Source: SEC EDGAR

accession 0001000228-23-000024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.